E/M Coding Alert - 2022 Issue 4
You Be the Coder: Revise Bilateral Ovarian Cancer Dx
Subscribe or sign in to view the full article.
Article Overview
This article reviews a change in ICD-10-CM that added a bilateral ovarian cancer option and discusses the related coding context for ovarian malignancy. It is aimed at coders and billing professionals who work with gynecologic oncology and diagnosis coding updates. The article also notes related code-groups and the presence of additional-code instructions for functional activity, helping readers understand the scope of the update without replacing the full coding guidance.
Why This Topic Matters
Accurate laterality reporting can affect diagnosis specificity, coding completeness, and claim consistency for ovarian cancer cases. The article helps readers recognize that an ICD-10-CM update changed how bilateral ovarian involvement is represented and that related secondary-malignancy and additional-code concepts may also be relevant.
Article Sections
-
Question
Introduces a coding question about ovarian cancer laterality following surgery and pathology findings.
-
Answer
Summarizes the ICD-10-CM update and places the topic in the context of ovarian cancer diagnosis coding.
-
Additional
Notes the presence of related additional-code guidance for ovarian neoplasm codes and names examples of associated functional-activity diagnoses.
-
Related
Mentions a related diagnosis code for secondary malignant neoplasm involving both ovaries.
What You Will Learn
- How an ICD-10-CM update affected reporting of bilateral ovarian cancer
- What broader ovarian neoplasm coding context is discussed
- Which related functional-activity diagnosis categories are referenced
- How the article frames primary versus secondary ovarian malignancy coding
Who Should Read This
- Medical coders
- Coding auditors
- Billing staff
- Gynecologic oncology practices
- Revenue cycle professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com